Giazo Tablets
Generic name:balsalazide disodium
Dosage form: tablet, film coated
Drug class:5-aminosalicylates
Medically reviewed by Drugs.com. Last updated on Dec 22, 2021.
On This Page
- Indications and Usage
- Dosage and Administration
- Dosage Forms and Strengths
- Contraindications
- Warnings and Precautions
- Adverse Reactions/Side Effects
- Drug Interactions
- Use In Specific Populations
- Overdosage
- Description
- Clinical Pharmacology
- Nonclinical Toxicology
- Clinical Studies
- References
- How Supplied/Storage and Handling
- Patient Counseling Information
The Giazo brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.
Indications and Usage for Giazo Tablets
GIAZO is indicated for the treatment of mildly to moderately active ulcerative colitis in male patients 18 years of age and older.
Limitations of Use:
- •
- Effectiveness of GIAZO in the treatment of female patients was not demonstrated in clinical trials [see Clinical Trials (14.1)].
- •
- Safety and effectiveness of GIAZO therapy beyond 8 weeks have not been established.
Giazo Tablets Dosage and Administration
The dose is three 1.1 g Giazo Tablets to be taken 2 times a day with or without food (6.6 g per day) for up to 8 weeks.
Dosage Forms and Strengths
GIAZO is available as yellow, oval, film-coated tablets containing 1.1 g balsalazide disodium, with “BZT” debossed on one side of the tablet.
Contraindications
GIAZO is contraindicated in patients with hypersensitivity to salicylates, aminosalicylates or their metabolites, or to any of the components of Giazo Tablets [see Description (11)].
